切换至 "中华医学电子期刊资源库"

中华消化病与影像杂志(电子版) ›› 2024, Vol. 14 ›› Issue (02) : 146 -150. doi: 10.3877/cma.j.issn.2095-2015.2024.02.009

论著

血清SAA、CA19-9结合超声内镜对结直肠癌术前分期的诊断价值
焦莉莉1, 周芊池1, 凌梦芸1, 魏红玲1, 徐缨1,()   
  1. 1. 210019 南京明基医院健康管理中心
  • 收稿日期:2023-10-09 出版日期:2024-04-01
  • 通信作者: 徐缨

Diagnostic value of serum SAA and CA19-9 combined with endoscopic ultrasonography in preoperative staging of colorectal cancer

Lili Jiao1, Qianchi Zhou1, Mengyun Ling1, Hongling Wei1, Ying Xu1,()   

  1. 1. Health Management Center, Nanjing Mingji Hospital, Nanjing 210019, China
  • Received:2023-10-09 Published:2024-04-01
  • Corresponding author: Ying Xu
引用本文:

焦莉莉, 周芊池, 凌梦芸, 魏红玲, 徐缨. 血清SAA、CA19-9结合超声内镜对结直肠癌术前分期的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(02): 146-150.

Lili Jiao, Qianchi Zhou, Mengyun Ling, Hongling Wei, Ying Xu. Diagnostic value of serum SAA and CA19-9 combined with endoscopic ultrasonography in preoperative staging of colorectal cancer[J/OL]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(02): 146-150.

目的

观察血清淀粉样蛋白A(SAA)、糖蛋白抗原(CA)19-9结合超声内镜(EUC)对结直肠癌(CRC)术前分期的诊断价值。

方法

选取2020年7月至2022年12月南京明基医院收治的并经病理证实的116例CRC患者为研究对象,均进行EUC检查,并检测血清SAA、CA19-9水平,采用ROC曲线分析血清SAA、CA19-9水平联合EUC预测CRC术前分期的诊断价值,并分析血清SAA水平与CA19-9水平的相关性。

结果

116例CRC患者中,病理分期为T1期22例,T2期28例,T3期46例,T4期20例;N0期66例,N1期30例,N2期20例;M0期100例,M1期16例。EUC诊断为T1期18例,T2期24例,T3期40例,T4期15例;N0期50例,N1期22例,N2期14例;M0期71例,M1期10例;EUC对直肠癌TNM分期的诊断率分别为83.62%、74.14%、69.83%。T分期中T4、T3、T2期的血清SAA、CA19-9水平高于T1期,T4、T3期的血清SAA、CA19-9水平高于T1、T2期,T4期的血清SAA、CA19-9水平高于T1、T2、T3期(P<0.05);N分期中N2、N1期的血清SAA、CA19-9水平高于N0期,N2期的血清SAA、CA19-9水平高于N0、N1期(P<0.05);M分期中M1期的血清SAA、CA19-9水平高于M0期(P<0.05)。ROC曲线分析显示,血清SAA、CA19-9水平联合EUC预测CRC术前分期的敏感度和AUC高于单独检测(P<0.05)。pearson相关分析显示,血清SAA水平与CA19-9的呈正相关(P<0.05)。

结论

血清SAA、CA19-9结合EUC对CRC术前分期的诊断价值较高,能够为治疗提供参考。

Objective

To observe the value of serum amyloid A (SAA) and glycoprotein antigen (CA)19-9 combined with endoscopic ultrasonography (EUC) in diagnosing preoperative stages of colorectal cancer (CRC).

Methods

A total of 116 patients with pathologically confirmed CRC who were admitted to Nanjing Mingji Hospital from July 2020 to December 2022 were selected as the study subjects. All of them received EUC and detection of serum SAA and CA19-9 levels. ROC curve was used to analyze the value of serum SAA and CA19-9 levels combined with EUC in preoperative staging of CRC. The correlation between serum SAA level and CA19-9 level was analyzed.

Results

For the 116 patients with CRC, the results of pathological staging showed 22 cases in T1 stage, 28 cases in T2 stage, 46 cases in T3 stage and 20 cases in T4 stage, 66 cases in N0 stage, 30 cases in N1 stage and 20 cases in N2 stage, 100 cases in M0 stage and 16 cases in M1 stage. The diagnostic results of EUC showed 18 cases in T1 stage, 24 cases in T2 stage, 40 cases in T3 stage and 15 cases in T4 stage, 50 cases in N0 stage, 22 cases in N1 stage and 14 cases in N2 stage, 71 cases in M0 stage and 10 cases in M1 stage. The coincidence rates of EUC for diagnosing TNM stages of CRC were 83.62%, 74.14%, and 69.83%, respectively. Serum SAA and CA19-9 levels in T4, T3 and T2 stages were higher than those in T1 stage. Serum SAA and CA19-9 levels in T4 and T3 stages were higher than those in T1 and T2 stages. Serum SAA and CA19-9 levels in T4 stage were higher than those in T1, T2 and T3 stages (P<0.05). Serum SAA and CA19-9 levels in N2 and N1 stages were higher than those in N0 stage. Serum SAA and CA19-9 levels in N2 stage were higher than those in N0 and N1 stages (P<0.05). Serum SAA and CA19-9 levels in M1 stage were higher than those in M0 stage (P<0.05). ROC curve analysis showed that the sensitivity and AUC of serum SAA and CA19-9 levels combined with EUC in diagnosing preoperative stages of CRC were higher than those of diagnosis alone (P<0.05). Pearson correlation analysis showed that serum SAA level was positively correlated with CA19-9 level (P<0.05).

Conclusion

EUC combined with serum SAA and CA19-9 levels is of high value in diagnosing preoperative stages of CRC. It can provide reference for treatment.

表1 超声内镜诊断CRC患者T分期与组织病理结果对照[例(%)]
表2 超声内镜诊断CRC患者N分期与组织病理结果对照[例(%)]
表3 超声内镜诊断CRC患者M分期与组织病理结果对照[例(%)]
表4 CRC患者不同病理分期的血清SAA、CA19-9水平比较(±s
图1 为血清SAA、CA19-9结合EUC对CRC术前分期的ROC曲线
表5 血清SAA、CA19-9结合ECU对CRC术前分期的ROC曲线分析
图2 血清SAA水平与CA19-9的相关性
[1]
谢健, 朱明艳, 李凯. 血浆循环肿瘤DNA SEPT9基因甲基化对结直肠癌诊断及预后预测价值分析[J]. 华南国防医学杂志, 2021, 35(5): 329-333.
[2]
王荟, 费秉元, 孙鸽, 等. 尿酸、NLR、及A/G对结直肠癌诊断的应用价值分析[J]. 中国实验诊断学, 2022, 26(8): 1250-1253.
[3]
王小平, 王诺凡, 陈小翔, 等. 血清miR-23a、miR-27a联合CEA在结直肠癌诊断中的临床价值[J]. 南京医科大学学报(自然科学版), 2022, 42(1): 58-62.
[4]
Okasha HH, Wahba M, Fontagnier E, et al. Hidden local recurrence of colorectal adenocarcinoma diagnosed by endoscopic ultrasound: A case series[J]. World J Gastrointest Endosc, 2022, 14(8): 502-507.
[5]
单旦萍, 李红胜, 吴晓燕, 等. 血清淀粉样蛋白A联合淋巴细胞亚群检测在结肠癌诊断中的应用价值[J]. 中国卫生检验杂志, 2022, 32(21): 2652-2654.
[6]
印滇, 杨莉, 曹莉莉, 等. 结直肠癌术后CTCs, CA125, CEA及CA19-9表达及与病理特征的关系[J]. 临床血液学杂志, 2021, 34(8): 536-540.
[7]
彭荣, 郝建成, 胡国权, 等. 256层螺旋CT动态增强及多模式后处理技术在结肠癌术前诊断及分期中的应用价值[J]. 安徽医药, 2020, 24(4): 137-141.
[8]
Oryani MA, Tavasoli A, Ghalavand MA, et al. Epigenetics and its therapeutic potential in colorectal cancer[J]. Epigenomics, 2022, 14(11): 683-697.
[9]
邱娅, 周仁冰, 吴仕吉, 等. MRT联合CTVE在结直肠癌术前分期诊断中的应用价值分析[J]. 中国CT和MRI杂志, 2020, 18(3): 45-477.
[10]
Gao Y, Hu JL, Zhang XX, et al. Accuracy of endoscopic ultrasound in rectal cancer and its use in transanal endoscopic microsurgery[J]. Minim Invasive Ther Allied Technol, 2020, 29(2): 90-97.
[11]
Minaga K, Takenaka M, Yamao K, et al. Clinical utility of treatment method conversion during single-session endoscopic ultrasound- guided biliary drainage[J]. World J Gastroenterol, 2020, 26(9): 947-959.
[12]
Davis TA, Conradie D, Shridas P, et al. Serum Amyloid A Promotes Inflammation-Associated Damage and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer[J]. Cell Mol Gastroenterol Hepatol, 2021, 12(4): 1329-1341.
[13]
董子瑜, 汪超. 炎症标记物对结直肠癌术后转移患者抗PD-L1免疫治疗效果的预测作用分析[J]. 中国中西医结合消化杂志, 2023, 31(1): 56-60.
[14]
Stewart KL, Gigic B, Himbert C, et al. Association of Sugar Intake with Inflammation- and Angiogenesis-Related Biomarkers in Newly Diagnosed Colorectal Cancer Patients[J]. Nutr Cancer, 2022, 74(5): 1636-1643.
[15]
Liu JM, Wang YY, Liu W, et al. Preoperative CA19-9: a competitive predictor of recurrence in patients with colorectal cancer liver metastases after hepatectomy[J]. Int J Colorectal Dis, 2021, 36(4): 767-778.
[16]
高楠, 刘羡伟, 黄蕾, 等. miR-107、SII、CA19-9在结直肠癌中的表达及与临床病理特征的关系[J]. 检验医学与临床, 2022, 19(5): 582-585.
[1] 袁庆港, 刘理想, 张亮, 周世振, 高波, 丁超, 管文贤. 尿素-肌酐比值(UCR)可预测结直肠癌患者术后的长期预后[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 506-509.
[2] 陈樽, 王平, 金华, 周美玲, 李青青, 黄永刚. 肌肉减少症预测结直肠癌术后切口疝发生的应用研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 639-644.
[3] 宋华传, 季鹏, 姚焕章, 王永帅, 张珅瑜, 宋瑞鹏, 王继洲. 腹腔镜肝切除术联合微波消融治疗多发性结直肠癌肝转移[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(04): 222-226.
[4] 赵泽云, 李建男, 王旻. 中性粒细胞胞外诱捕网在结直肠癌中的研究进展[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 524-528.
[5] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[6] 张金珠, 梅世文, 孙金峰, 胡刚, 邱文龙, 李国利, 汪欣, 王锡山, 汤坚强. 原发结直肠癌超系膜切除术后患者的生存危险因素分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(03): 197-204.
[7] 王国强, 张纲, 唐建坡, 张玉国, 杨永江. LINC00839 调节miR-17-5p/WEE1 轴对结直肠癌细胞增殖、凋亡和迁移的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 491-499.
[8] 孙晗, 于冰, 武侠, 周熙朗. 基于循环肿瘤DNA 甲基化的结直肠癌筛查预测模型的构建与验证[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 500-506.
[9] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[10] 高静, 夏婷婷. 血清乳酸脱氢酶、中性粒细胞/淋巴细胞比值、血浆纤维蛋白原/前白蛋白比值对晚期结直肠癌患者姑息化疗效果与不良反应的评价[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(03): 203-207.
[11] 王湛, 李文坤, 杨奕, 徐芳, 周敏思, 苏珈仪, 王亚丹, 吴静. 炎症指标在早发性结直肠肿瘤中的应用[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 802-810.
[12] 李惠凯. EUS-FNA联合EPMB诊断胃壁增厚性疾病[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(04): 288-288.
[13] 曹友红, 吕翔, 张康伟, 袁晨, 徐甜, 唐月华, 马亦旻, 邢一鸣, 张以洋. 基于EUS 引导下ESD 对食管上皮下鱼刺的治疗[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(04): 243-247.
[14] 程冰倩, 柴宁莉, 杜晨, 王湛博, 李惠凯, 冯秀雪, 高飞, 令狐恩强. 超声内镜引导下经穿刺针活检钳活检在胰腺囊性肿瘤诊断中的应用[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(03): 147-152.
[15] 沈聪强, 田新宇, 米热阿依·努尔麦麦提, 庄宇航, 张松, 彭春艳, 黄淑玲, 沈珊珊, 张玮, 吕瑛. 胰腺导管内管状乳头状肿瘤的超声内镜特征分析[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(03): 153-158.
阅读次数
全文


摘要